ENSARTINIB

Clinical trials for ENSARTINIB explained in plain language.

Never miss a new study

Get alerted when new ENSARTINIB trials appear

Sign up with your email to follow new studies for ENSARTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Targeted drug trial aims to extend remission for Tough-to-Treat lung cancer

Disease control Not yet recruiting

This study is testing whether adding the targeted drug ensartinib after standard chemoradiation can better control advanced, inoperable lung cancer in patients with a specific genetic change (ALK mutation). It will involve about 45 patients who have completed initial treatment wi…

Matched conditions: ENSARTINIB

Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control

Last updated Mar 05, 2026 13:59 UTC

ENSARTINIB

Get alerted when new ENSARTINIB trials appear

Targeted drug trial aims to extend remission for Tough-to-Treat lung cancer